HUMIRA

Solution for injection in pre-filled syringe, 20mg/0.2ml
RxActive license

Active substance (INN)

adalimumab

Pharmaceutical form

Pharmaceutical formSolution for injection in pre-filled syringe
Strength20mg/0.2ml
PackagingUkupno 2 napunjena injekciona šprica sa po 0.2ml rastvora za injekciju u kartonskoj kutiji
ManufacturerAbbVie Biotechnology GmbH, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L04AB04)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateFebruary 21, 2019

Analogs in Montenegro

7

Other medicines with the same active substance

HUKYNDRARx
Solution for injection in pre-filled syringe, 40mgStada Arzneimittel AG
HUKYNDRARx
Solution for injection in pre-filled syringe, 80mgStada Arzneimittel AG
HUKYNDRARx
Solution for injection in pre-filled pen, 40mgStada Arzneimittel AG
HUMIRARx
Solution for injection in pre-filled pen, 80mgAbbVie Biotechnology GmbH
HUMIRA®Rx
Solution for injection in pre-filled syringe, 40mg/0.4mlAbbVie Biotechnology GmbH & Co. KG
HYRIMOZRx
Solution for injection in pre-filled pen, 40mg/0.8mlSandoz GmbH Schaftenau
HYRIMOZRx
Solution for injection in pre-filled syringe, 40mg/0.8mlSandoz GmbH Schaftenau
Source: CInMED register